Protalix Biotherapeutics Inc (NYSE MKT LLC:PLX)

1.96
Delayed Data
As of Jul 02
 +0.05 / +2.62%
Today’s Change
1.53
Today|||52-Week Range
3.65
+6.52%
Year-to-Date
No recent news for Protalix Biotherapeutics Inc.

Today’s Trading

Previous close1.91
Today’s open1.90
Day’s range1.88 - 1.96
Volume65,279
Average volume (3 months)369,302
Market cap$183.5M
Dividend yield--
Data as of 4:04pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-6.67%
Earnings growth (this year)0.00%
Earnings growth (next 5 years)+25.00%
Revenue growth (last year)+31.68%
P/E ratioNM
Price/Sales11.27
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FATEFate Therapeutics In...+0.17+2.54%
ENZYEnzymotec Ltd+0.13+1.60%
CURNeuralstem Inc+0.08+4.28%
PSTIPluristem Therapeuti...-0.05-1.99%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateSeptember 2, 2015
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$15.2M
Annual profit (last year)-$29.9M
Net profit margin-197.51%

Profile

Sector
Health Services
Industry
Services to the Health Industry
President, Chief Executive Officer &
Director
Moshe Manor
Chief Operating Officer
Tzvi Palash
Corporate headquarters
Carmiel, Haifa

Forecasts

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers